stella
beta
Real-World Study of Iruplinalkib in the Treatment of ALK-Positive Non-Small Cell Lung Cancer — Stella
Home
/
Non-small Cell Lung Cancer (NSCLC)
/
View on ClinicalTrials.gov
Recruiting
Back to Non-small Cell Lung Cancer (NSCLC) trials
Trial locations
(1 site)
China
Shandong Cancer Hospital and Institute, Jinan, Shandong